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Resistance to antifungal drugs is an increasing issue in treating disease caused by the 
fungal pathogen Candida albicans. As a step towards new antifungal approaches, we 
investigated antifungal delivery of molecules to C. albicans cells using the cell-
  
penetrating peptide, MPG, genetically fused to the model cargo, green fluorescent 
protein (GFP). We varied the orientation of the fusion of GFP to MPG and evaluated 
translocation into the cells. We found fusing the GFP to the C-terminus of the peptide 
resulted in translocation into almost 5% of C. albicans cells, while fusion of GFP to 
the N-terminus of the peptide resulted in translocation into less than 0.3% of cells. Our 
results indicate that fusion of cargo to the C-terminus of MPG is preferred for 
intracellular delivery of cargo, but further research to improve the efficiency of 
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Chapter 1: Background and motivation 
1.1 Fungal infection and Candida albicans 
Candida species are the most common human fungal pathogens1, and the infection 
caused by these pathogens is called candidiasis. Candidiasis can affect human mucosal 
surfaces or skin, like vulvovaginal and oropharyngeal candidiasis, or it can cause a 
systemic, life-threatening infection by invading different organs of the body1,2.  
 
Candida albicans is the most common species of Candida that is collected from 
patients diagnosed with candidiasis. An 
important characteristic of C. albicans is its 
ability to grow in two major forms, namely, 
yeast and hyphal forms (Figure 1.1), making it 
dimorphic. Studies have shown that the hyphal 
form has more adherence to organs and tissues, 
which is required by C. albicans for invasion, 
while the yeast form is responsible for spread of 
infection1. If the hyphal transition is inhibited in C. albicans, the yeast form of the cells 
will still infect tissues and organs, but the severity and lethality of infection was 
observed to be much less compared to when filamentation of C. albicans occurs1. The 
growth conditions are an important factor for the dimorphic transition, with the 
combination of 37 ℃ and pH=7 being the best physical conditions for hyphal 
Figure 1.1 The dimorphic switch. C. albicans switch 
from (a) yeast form to (b) hyphal form. The scale bar 
represents 10 μm. Figure reprinted with permission 






formation3. The nutrients in the growth media are of high importance as well. For 
example, horse serum was introduced in the media for transition to hyphal form3. 
 
C. albicans is present as a commensal in the human skin, mouth, gut, vagina, and 
mucous membranes1. It can cause systematic infections when the conditions for growth 
and proliferation are provided by the environment inside the body of individuals with 
suppressed immune systems. It can also cause less severe infections, such as vaginal 
candidiasis, in healthy individuals under certain conditions that cause disturbance to 
normal flora, like taking antibiotics1,2,4. The mortality rate of C. albicans infections is 
reported to be up to 50%5, and the ability of these fungal pathogens to develop 
resistance to current antifungal treatments is even increasing the death caused by 
Candida infections6,7.  
 
1.1.1 Candidiasis treatments 
Different classes of antifungal agents have been used to treat infections caused by C. 
albicans and other Candida species including azoles, echinocandins and polyenes 
(Figure 1.2)1,2,8. 
 
Azoles are a large family of Food and Drug Administration (FDA)-approved 
antifungals which includes fluconazole, itraconazole, voriconazole, and posaconazole2. 
Azoles target the lanosterol 14-α-demethylase and inhibit its enzymatic activity for 
biosynthesis of the ergosterol, one of the important components of the yeast's cell 





an intrinsic resistance (meaning they are naturally resistant) to one or more members 
of the azole family, and resistance can also develop over the course of treatment of C. 
albicans infection with azoles 1. 
 
Another FDA-approved family that is prescribed to patients with invasive candidiasis 
is echinocandins, including anidulafungin, caspofungin, and micofungin. This family 
is a lipopeptide antifungal agent that disturbs the fungal cell wall by inhibiting the 
enzyme (1,3)-β-D-glucan synthase, which is responsible for production of glucan. In 
most cases, echinocandins are prescribed as an alternative to people with azole resistant 
candidiasis, but Candida can gain resistance to this family as well2,9. 
 
Polyenes are another frequently used antifungal family. This family includes 
amphotericin B and nystatin. This antifungal family, like the azoles and echinocandins, 
targets ergosterol and kills Candida by invading the cell membrane through an aqueous 
pore formation by binding ergosterol. The pore causes leakage of the components of 
the cytosol leading to cell death. Although Candida species have developed minimal 
resistance to amphotericin B over the years, the toxicity and side effects of polyenes 
limits their use9.  
 
Considering the limitations of currently available antifungal agents, such as adverse 
effects, drug-drug interactions, and gaining resistance, developing new technology to 






1.2 Cell-penetrating peptides (CPPs) 
To help drive the development of new antifungal agents forward, we have studied the 
use of cell-penetrating peptides (CPPs) to deliver molecules into fungal cells. CPPs can 
cross the cell membrane and take other molecules with them, and they are a promising 
tool in drug delivery. Understanding their interaction with molecules that need 
assistance in crossing the cell membrane to reach intracellular targets is necessary.   
 
1.2.1 The cell membrane as a barrier to intracellular delivery 
In recent decades, much research has been done for the intracellular delivery of 
therapeutic agents, but the hydrophobic nature of the cellular membrane is a big barrier 
for bioactive molecules that are hydrophilic to enter the cells (Figure 1.3)10. The 
amphipathic phospholipid bilayer, with its hydrophilic portion facing the outside 
environment of the cells, selectively rejects the entrance of charged ions of any sizes 
and large polar molecules, including amino acids 11, so a strategy to deliver these 
molecules to the cytoplasm is required. Drugs have been delivered using several 
methods, including liposomes, polymeric micelles, and viral vectors, but there are 








Figure 1.2 Selective permeability of cell membrane. Small uncharged polar or nonpolar molecules 
can cross, but the charged ions and charged or uncharged large polar molecules are rejected. Figure 
reproduced with permission of Geoffrey M Cooper through PLSclear. Copyright 2000 Oxford 
Publishing Limited 11. 
 
1.2.2. CPPs as drug delivery agents 
CPPs are short peptides, typically consisting of less than 30 amino acids, that can cross 
cell membranes and shuttle a wide variety of cargos inside the cells. So far, the 
translocation of CPPs by mammalian, plant, bacterial, yeast, and insect cells have been 
reported13.  
 
Up to now, no CPP or CPP-cargo complex has been approved by the FDA, although 
some drugs have been evaluated in the preclinical phase and the subsequent phases I, 
II and III trials 14. One example of a CPP-facilitated therapy in the preclinical trial is 
the MPG-8-siRNA for cancer therapy. MPG-8 
(AFLGWLGAWGTMGWSPKKKRK), is a shorter version of the peptide MPG that is 





tumor mouse models, successfully demonstrating reduction in the size of the tumor14. 
The first CPP-derived drug that entered a clinical trial was the conjugation of a 
polyarginine to cyclosporine A the CsA (PsorBan; CellGate, Inc.) to treat psoriasis. 
Cyclosporine A can be used for the treatment of psoriasis, but it is ineffective due to 
lack of mechanism for entrance into the dermis of human skin15. The CPP-based drug 
passed phase I of the clinical trial, but phase II was discontinued due to the slow rate 
of releasing the drug14,15.  
 
1.2.3. Translocation mechanisms 
The exact mechanism of translocation of CPPs varies from one CPP to another and can 
depend on the experimental conditions. Endocytosis and direct translocation are 
mechanisms that are reported for CPPs (Figure 1.4)12. Endocytosis is an energy-
dependent pathway, which the cell uses to selectively remove particles like food and 
nutrients, from the surface of the cell and take them inside. Endocytosis can be further 
divided into macropinocytosis, endocytosis mediated by caveolae or clathrin receptor 
proteins, and caveolae- and clathrin-independent endocytosis12,16,17 (Figure 1.3). In 
macropinocytosis, dynamin proteins participate in the development of new vesicles 
from the cell membrane's exterior surface, called macropinosomes 16. This pathway 
needs a stimulus to function, like growth factors or viruses12. In receptor-mediated 
endocytosis, including caveolae- or clathrin-mediated uptake, after interaction and 
binding of the particles to the receptors, clathrin and caveolin proteins facilitate the 
formation of clathrin- or caveolin-coated (also called caveosome) vesicles 16(Figure 





endocytosis are possible to be used by the same CPP for internalization into cells12. A 
challenge with energy-dependent uptake is the endosomal escape after internalization. 
If the CPPs get trapped in the vesicle, they will undergo lysosomal degradation12. 
 
The direct translocation pathway is an energy-independent penetration of CPPs, and it 
usually takes place in the presence of amphipathic CPPs at high concentrations. Direct 
translocation can occur through different mechanisms, namely, the inverted micelle 
formation, pore formation, carpet-like model, and membrane-thinning model16. In all 
these mechanisms, the uptake is activated after the CPPs are attracted to the membrane 
via electrostatic interactions. In the inverted micelle model, in addition to the attraction 
between negatively charged components of the membrane and the positively charged 
portion of the CPPs, the interaction between the hydrophobic parts of the membrane 
and the CPPs help the translocation16. Pore formation is described by different models, 
one being the toroidal model. In the toroidal model both, the CPP and the lipid 
participate in pore formation in a way that lipids curve to let the CPP get close to the 
lipid head groups, and the pore will form16. In the membrane thinning and the carpet-
like model, respectively, the thinning and the carpeting of the membrane befalls 
because of the electrostatic interactions between the cationic CPP and the membrane, 






Figure 1.3 Different pathways for uptake and release of the cell-penetrating peptides. CPPs into 
the cells via different pathways. Figure reprinted with permission from Copolovici et al. Copyright 2014 
American Chemical Society 12. 
 
 
Many factors affect the mechanism of action of CPPs. For example, CPPs that take the 
endocytosis pathway at low concentration might employ direct translocation at higher 
concentration of peptide16. The secondary structure of the peptide also plays a role in 
the mechanism, since the secondary structure that CPPs adopt can affect the distribution 
of side chains with different properties. For example, a peptide upon formation of α-





have different membrane composition, so the mechanism of action of each CPP should 
be studied for each type of cell separately18.  
 
1.2.4. Types of CPPs 
CPPs are classified in many ways. One common way is to group them based on their 
physical-chemical properties: cationic, hydrophobic, and amphipathic CPPs (Table 
1.1).  
 
Cationic CPPs: Cationic CPPs are known for their high positive net charge and are 
mainly composed of the cationic amino acids namely, arginine, lysine, and histidine. 
Even if peptides are not cationic overall, many of them include positively charged 
residues in their structures12, since the positive charges are important to initiate binding 
to the negatively charged phospholipid bilayer of the membrane13. Based on the data 
for a number of cationic CPPs, at least eight positively charged residues are required 
for the efficient uptake by the cells19,20. Examples of cationic peptides include 
polyarginines and penetratin10 (Table 1.1). The nuclear localization sequences (NLS) 
that target peptides to the nucleus are members of the cationic CPP classification10. It 
is worth mentioning that some cationic CPPs can impact cell viability and membrane 
integrity19. 
 
Hydrophobic CPPs: Hydrophobic CPPs are made up primarily of residues with polar 
side chains12.  They have low net charge, but their hydrophobicity is an important factor 





to-date (for example, C105Y and Pep-7; Table 1.1), and it has been suggested that these 
CPPs can translocate into the cells via an energy-independent mechanism14.  
 
Amphipathic CPPs: Amphipathic CPPs have both a charged domain and a 
hydrophobic domain. They are divided into two subgroups of primary and secondary 
amphipathic CPPs14. Primary amphipathic CPPs have charged and hydrophobic 
domains on opposite ends of the primary sequence of the peptide. They can be chimeric 
constructs obtained from the combination of a cationic CPP with a hydrophobic 
domain, such as the peptide MPG and Pep-1 (Table 1.1), or can be naturally derived 
from proteins, such as pVEC14,16 (Table 1.1). Secondary amphipathic CPPs are those 
that, after the transition to a secondary structure like an α-helical structure, form an 
amphipathic structure by having hydrophilic residues on one side and hydrophobic 
residues on the other side, like MAP14.  
 
Table 1.1 CPP sequence, origin and classification based on cationic, hydrophobic, and 
amphipathic. Table recreated from12,14 
CPPs Sequence Origin 
Cationic 
Penetration RQIKIWFQNRRMKWKK Antennapedia homeodomain 
Polyarginines Rn Synthetic 
Amphipathic 
MPG GALFLGFLGAAGSTMGAWSQPKKKRK HIV glycoprotein 41/SV40 T antigen 
NLS 
pVEC LLIILRRRIRKQAHAHSK Vascular endothelial cadherin 





Pep-1 KETWWETWWTEWSQPKKKRKV Tryptophan-rich cluster/SV40T 
antigen NLS 
Hydrophobic 
C105Y CSIPPEVKFNKPFVYLI a1-Antitrypsin 
Pep-7 SDLWEMMMVSLACQY CHL8 peptide phage clone 
 
1.2.5. CPP-cargo attachment  
Regardless of the limited knowledge of how CPPs exactly pass through the membrane, 
their ability to do so is exploited to deliver therapeutics into the cells10. The attachment 
of cargo to CPPs can occur through covalent bonding or non-covalent interactions 
(Figure 1.4). In covalent bonding, the cargo and CPP are linked together through a 
covalent bond. In this case the position of cargo with respect to the CPP needs to be 
considered. The cargo can be attached to the N- or C-terminus of the CPP or to the side 
chain of an amino acid within the peptide. Examples of covalent bonds used to attach 
cargo to CPPs are disulfide bonds and peptide bonds20,21. Genetic fusion of a protein 
cargo to a CPP and recombinantly expressing the fusion CPP-cargo takes advantage of 
the covalent attachment through a peptide bond. Using covalent linkage of cargo to the 
peptide has the advantage of controlled release of cargo inside the cells, like how a 
disulfide bond is reduced in the reducing environment of the cells thus releasing the 
drug20. Another reason that covalent linkage sometimes is preferred over noncovalent 
linkage is that it facilitates the production of larger and more complex protein cargos 






Non-covalent attachment of cargo to the CPP involves interactions of the CPP with the 
surface of the cargo through electrostatics, ᴨ-ᴨ stacking, hydrophobic interactions, or 
H-H bonds23. The complex formed by non-covalent bonds can be very challenging to 
characterize, since formation of aggregates leads to complicated secondary and tertiary 
structures12. One common example of non-covalent bonding is the attachment of 
negatively charged DNA backbone to the cationic CPPs via electrostatic interactions20. 
 
Figure 1.4 Examples of different methods of cargo attachment to the CPP. Cargo is attached to CPPs 
via covalent bond or non-covalent. Figure is recreated from 20. 
 
1.3 CPPs and C. albicans cells 
Since the introduction of CPPs and their unique ability to carry a large variety of cargos 
across the cell plasma membrane, researchers have contributed to over 2000 papers 
about CPPs15. Most of the studies done on CPPs have focused on their application in 
mammalian cell lines, and little work has been done to study their translocation into 
fungal cells18,24–26. In this part of the thesis, some of the work that has been done on 





1.3.1 Mechanism of entry into C. albicans 
Although many of CPPs have been characterized for their mechanism of entry into 
mammalian cells, this mechanism may be different in fungal cells due to the presence 
of the cell wall and different cell-surface proteins in fungal cells25. Gong et al. 
investigated the mechanism of entry of some peptides into the C. albicans and 
compared the results to published mechanisms in mammalian cells25 (Table 2). They 
found the mechanism of translocation of the CPPs is variable, and it highly depends on 
the CPP being used and the type of cell in the experiment25. 
 
Table 1.2 Comparison of translocation mechanism in fungal cells and mammalian cells. 
Recreated from 25. 





m in fungal 
cell* 
pVEC LLIILRRRIRKQAHAHSK 2209.7 M E/M 
MAP KLALKLALKALKAALKLA 1876.0 E E/D 
synB RGGRLSYSRRRFSTSTGR 2100.3 E E 
MPG GALFLGFLGAAGSTMGAWSQPKKK
RKV 
2807.4 D E 
hCT LGTYTQDFNKTFPQTAIGVGAP 2323.6 E ND 
Penetratin RQIKIWFQNRRMKWKK 2246.8 M M/D 
*The mechanisms are listed as endocytosis (E), direct translocation (D), micropinocytosis (M), or no translocation detected (ND). 
 
The secondary structure that the CPPs adopt in the aqueous environment may differ 
from the structure gained in the presence of different cell types. Many factors like the 
overall charge, hydrogen bonds, environment, and helical properties of the peptide 
might cause changes in the secondary structure of the CPPs12. Thus, understanding the 





interaction and translocation12. Circular dichroism (CD) was used by Gong et al. to 
study the secondary structure of the CPPs in different environments and in the presence 
of live cells. Subsequently, the results were combined with Monte Carlo simulations 
with a model membrane to better understand the CPP-membrane interaction and the 
translocation mechanism18. The Monte Carlo simulations showed the main driving 
force for the interaction of the CPPs with the cell membrane was the electrostatic 
interactions between the positively charged residues and the lipid bilayer. For peptides 
expected to translocate via a direct translocation mechanism (Table 1.2), the 
simulations showed the peptides interacted with the hydrophobic portion of the 
membrane, and these peptides, which require a hydrophobic environment to form their 
α-helical secondary structure, also exhibited α-helical structure in the CD with live 
cells. For peptides expected to translocate by endocytosis, the Monte Carlo simulation 
predicted no secondary structure formation, and the driving force for internalization 
was still the electrostatic interactions. These results indicate that these peptides attached 
to the cell membrane but did not interact with the hydrophobic portion of the 
membrane, and they translocated via an energy dependent pathway. 
 
1.3.2 Translocation of CPP into C. albicans cells 
The translocation of different model cargos into C. albicans cells has been studied 
previously. Some CPPs efficiently caried a fluorescein fluorescent label as their small-
molecule model cargo into the C. albicans cells25. Among the peptides that were 
studied for translocation into the cells, pVEC, MAP, synB, penetratin, and MPG 





towards the cells was high, indicating these peptides can act as an antifungal peptide 
while translocating. 
 
The ability of CPPs to carry a large cargo fused to its N- or C-terminus inside the cells 
has also been evaluated27. The model cargo was typically green fluorescent protein 
(GFP) which is 27 kDa in size. A number of peptides have been reported to carry GFP 
into C. albicans cells with the GFP attached to the C-terminus of the peptide, including 
pVEC, MAP and MPG, though the level of translocation varied25. Of particular interest 
to this thesis, previous work in our lab showed that MPG attached to GFP carried the 
cargo into about 40% of C. albicans cells27. In this case, the GFP was attached to the 
N-terminus of the peptide, with no work to understand if this was the best orientation 
of the CPP and cargo. 
 
1.4 Overview of the thesis  
In this thesis, we studied the best location of the protein cargo, with respect to the 
peptide MPG, to efficiently translocate the cargo into C. albicans cells. We studied the 
translocation of constructs with GFP fused to the N- and C-terminus of MPG. In 
Chapter 2, detailed experimental processes are described for the construction, 
expression, extraction, and purification of the constructs, as well as the process for 
quantification of their translocation into the C. albicans cells. The analysis of the results 
of the experiments and discussions of the data are presented in Chapter 3. Finally, in 
Chapter 4, we present our conclusion of the work and propose ideas for designing new 






Chapter 2: Material and methods 
2.1 Recombinant protein design and construction 
Two different fusion proteins with the cargo at the N-terminus of the fusion protein 
were built for this study: one with the T7 tag at the N-terminus and the other without 
the T7 tag. The fusion protein with the cargo at the C-terminus of the CPP was 
constructed for a previous study29–31. 
 
2.1.1 Cloning 
The CPP fusions to GFP and controls with no CPP were cloned into the pET21(a)+ 
plasmid (Novagen) for expression. The plasmids created and the primers used in this 
study are listed in Tables 4 and 3, respectively. The primers were all designed for this 
study and commercially synthesized (IDT DNA or Genewiz). 
 
Table 2.1 Oligonucleotide sequences 
Oligonucleotide 
sequence name 
Sequence (5' to 3') 
GFP-FWD1 TTGTTTAACTTTAAGAAGGAGATATACATATGCACCACCACCAC
CACCACATTGAGGGAC  
GFP- FWD2 TAGCTGAATTCACATGCACCACCACCACCACCACATTGAG 

















































Table 2.2 List of plasmids. All the constructs are inserted into pET21a(+) plasmid 
Plasmid name Relevant characteristics Reference 
MPG-G4S-GFP GFP fused to the C-terminus of MPG, C-terminal 6×His, G4S 
linker between GPF and MPG 
29,32 
GFP-G4S-MPG GFP fused to the N-terminus of MPG, N-terminal 6×His tag, 
factor Xa site after 6×His, G4S linker between GPF and MPG 
This study 
GFP-6×His C-terminal 6×His tag This study 
T7-6×His-GFP N- terminal T7 tag followed by a factor Xa site and 6×His tag. This study 
T7-GFP-G4S-MPG GFP fused to the N-terminus of MPG, N-terminal T7 tag 
followed by a factor Xa site and 6×His tag, G4S linker between 
GPF and MPG 
This study 
 
 To construct the plasmids GFP-G4S-MPG and 6×His-GFP, we first amplified GFP 
from the MPG-G4S-GFP plasmid listed in Table 2.229,32, using a two-step polymerase 
chain reaction (PCR) amplification. Primers GFP-FWD1 and GFP-REV1 were used 
for the first step. For the GFP-G4S-MPG plasmid, the PCR product of first step was 
directly used as a template for the second step of PCR amplification using GFP-FWD2 
and GFP-REV1 primers. For the 6×His-GFP plasmid, which served as a negative 
control to make sure GFP will not translocation into the cells by itself, the same product 
from the first PCR step of GFP amplification was used as the template for the second 
step of PCR amplification with primers GFP-FWD2 and GFP-Stop-Rev to add a stop 





step PCR products were purified (Wizard CV kit, Promega) and digested with EcoRI 
(New England Biolabs) and SalI-HF (New England Biolabs) restriction enzymes to 
prepare for insertion into the plasmid. 
 
The DNA encoding MPG and the linker was prepared via dimerization of two pairs of 
complementary DNA oligonucleotides (Figure 2.1) (Pair 1: MPG-Bottom1 and MPG-
Top1; Pair 2: MPG-Bottom2 and MPG Top2). The DNA coding for the G4S peptide 
linker and the CPP with sticky ends complementary to SalI and NotI restriction sites 
was included in the oligonucleotide design for easy insertion into the plasmid. The 
BamHI restriction site was included between the linker peptide sequence and the CPP 
to facilitate exchange of the CPP DNA in the plasmid to encode other CPPs. To prepare 
the oligonucleotide dimers for insertion into the plasmid, the 5' ends of the 
complementary oligonucleotides were phosphorylated using T4 polynucleotide kinase 
(New England Biolabs) and annealed together in a C1000 thermal cycler (Bio-Rad) 
programmed to incubate at 95 ℃ for 2 min and cool down to 20 ℃ over 15 min to form 
a double-stranded DNA construct. The oligonucleotides MPG-Bottom1 and MPG-top1 
were annealed together and formed a double-stranded DNA construct with a 5' sticky 
end for the SalI restriction enzyme site and with a 3' end containing a complementary 
overhang to the 5' end of the annealed MPG-Top2 and MPG-Bottom2 DNA construct, 
which had a 3' sticky end for the NotI restriction enzyme site. 
 
The pET21a(+) plasmid was digested using EcoRI and NotI-HF enzymes to prepare 





DNA encoding for GFP, and MPG were ligated together using T4 DNA ligase (New 
England Biolabs) at 16 ℃ overnight, producing the GFP-G4S-MPG and 6×His-GFP 
plasmids (Figure 2.1).  
 
 
Figure 2.1 Schematic overview of the oligonucleotide dimerization and insertion into pET21a (+) 
vector. (a) Pairs of complementary oligonucleotides were designed, (b) dimerization was done in a 
thermal cycler, (c) the hydrogen bonding between G-C and A-T base pairs created: Pair 1 with sticky 
end for SalI restriction enzyme site and Pair 2 with sticky ends for NotI restriction enzyme site, (d) 
pET21a (+) was digested with NotI and EcoRI, and (e) MPG and GFP DNAs were ligated into the vector. 






For the plasmids containing the T7 tag with MPG and without MPG, a similar process 
was used, except the primers were different. GFP was amplified from the MPG-G4S-
GFP1,4 using primers 6×His-GFP-FWD1 and GFP-REV1. To construct the T7-GFP-
G4S-MPG plasmid, the amplified GFP was used as a template for another PCR step 
using primers ECORI-FacXa-FWD2 and GFP-REV1, while for the T7-6×His-GFP 
plasmid, the primers ECORI-FacXa-FWD2 and GFP-Stop-Rev were used. The 












Figure 2.2 Plasmid maps. a) Plasmid map of T7-GFP-G4S-MPG and b) T7-GFP-6×His. The relevant 
restriction enzyme sites are shown on the figure. 
 
2.1.2 Transformation and screening  
The circular DNA obtained from the ligation step was transformed into 
electrocompetent cells of the E. coli BL21(DE3) strain (Novagan) via electroporation. 
BL21(DE3) contains the gene for the expression of T7 RNA polymerase under 
regulation of the lacUV5 promoter, which is inducible by isopropyl β-D-1-
thiogalactopyranoside (IPTG)33,34. BL21(DE3) was used as the host strain for 





BL21(DE3) electrocompetent cell suspension, and then the cell suspension was 
shocked using Gene Pulser Xcell instrument (Bio-Rad). The cells were allowed to 
recover for 1 h in super optimal broth with catabolite (SOC) media (2% tryptone, 0.5% 
yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM 
glucose) at 37 ℃ while shaking at 225 RPM before spreading the cells on LB agar 
plates (15 mg/mL agar, 10 mg/mL tryptone, 10 mg/mL NaCl and 5 mg/mL yeast 
extract) containing ampicillin 100 μg/mL and IPTG at 0.01 mM.  
 
After overnight incubation of the plate at 37 ℃, we picked 3 or 4 colonies that were 
green (indicating GFP expression) from the plate and grew them overnight in Luria 
Bertani (LB) liquid medium (10 mg/mL tryptone, 10 mg/mL NaCl and 5 mg/mL yeast 
extract) containing ampicillin (100 µg/mL). DNA was extracted from the culture for 
each colony using the Wizard Promoga miniprep kit according to the manufacturer’s 
protocol. The purified DNA was further screened for insertion of CPPs via PCR 
amplification using appropriate primers. For example, for 6xHis-GFP-G4S-MPG, we 
used MPG-Top1 and MPG-Bottom2 for the PCR screening. The size of the PCR 
product was visualized in a 1% agarose gel to confirm a band around 100 base pairs 
depending on the size of the DNA encoding for the CPP. After screening for GFP 
expression and CPP gene presence, we sent the plasmids that passed both tests for 
Sangar sequencing (Genewiz) to confirm the sequences. A freezer stock was prepared 
from each overnight culture for long-term storage by mixing a 1:1 volume ratio of 50% 






2.2 Protein expression  
To express protein for downstream assays, we grew the cells overnight from the freezer 
stock in 20 mL liquid LB media containing ampicillin (100 μg/mL). After overnight 
growth at 37 °C while shaking at 225 RPM, the optical density at 600 nm was 
measured, and cells were subcultured into 1000 mL of fresh LB media containing 
ampicillin to an optical density at 600 nm of 0.05. After growing the subculture for 
about two and half hours at 37 °C while shaking at 225 RPM, production of the target 
protein was induced by adding IPTG (Fisher Bioreagents) to a final concentration of 
0.01 mM. Six hours after beginning induction, cells were harvested via centrifugation 
at 4300 × g and 4 ℃ for 20 min. We discarded the supernatant and saved the pellet for 
extraction and purification of desired protein. 
 
2.3 Target protein extraction and purification 
 
2.3.1 Protein extraction  
 
Cell pellets were resuspended in 17 mL of equilibration buffer (500mM NaCl, 50mM 
sodium phosphate (NaPB), pH 7.5). A 25 μL volume of 100× protease inhibitor stock 
(MilliporoSigma) was added to the suspension to inhibit the protease activity. In cases 
where the suspension was viscous, 10 μL of benzonase nuclease (MilliporeSigma) was 
added to the suspension. The cell suspensions were then lysed using a homogenizer 
cell disruption system (Avestin, Inc.) and centrifuged to separate the cell debris from 





supernatant (hereinafter known as “lysate”) was saved and passed through a 0.45 μm 
sterile filter and saved for downstream assays. 
 
2.3.2 Protein purification  
The protein purification was done using immobilized metal affinity chromatography 
(IMAC). The nickel-charged iminodiacetic acid (NIDA) resins for IMAC and 
appropriate columns were purchased from Bio-Rad, and about 5 mL of resin was 
loaded to each column. After equilibrating the column with 5 column volumes of 
equilibration buffer (500mM NaCl, 50mM NaPB, pH 7.5), the lysate was loaded onto 
the column, and the column was incubated with rotation for 45 mins at room 
temperature or up to 2 h at 4 ℃. After incubation, the flowthrough of each column was 
collected, and the resin was washed with 5 column volumes of equilibration buffer to 
remove residual unbound proteins. This wash was collected as Wash 1. The column 
was then washed with equilibration buffer containing 10 mM imidazole to remove any 
loosely bound proteins, and this wash was collected as Wash 2. Finally, the target 
protein was eluted using buffer containing 300 mM imidazole (500mM NaCl, 50mM 
NaPB, 300 mM imidazole, pH 7.5). 
 
2.4 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
After purification, we analyzed the collected flowthrough, Wash1, Wash2 and eluate 





Lambert Law, using a Nanodrop instrument (Thermo Scientific) to measure the 
absorbance at 280 nm and the extinction factor and size for each sample noted in Table 
2.3. A 20 μL solution containing 2 μg of protein and 1× SDS-dye (0.05 M Tris-HCl, 
0.1 M dithiothreitol (DTT), 8% (w/v) SDS, 1.5 mM bromophenol blue, and 1.075 M 
Glycerol) was prepared and heated at 98 ℃ for 5 min to denature the protein. Then 15 
μL of solution was loaded to an Any KD Mini-Protein TGX 15-well gel (Bio-Rad) 
along with a molecular weight marker (Precision Plus Protein Standards; Bio-Rad). 
The gel was run at 200 V for 30 mins to separate fragments based on their size. The gel 
was stained using Bio-Safe Coomassie (Bio-Rad) according to the manufacturer’s 
protocol and imaged using a ChemiDoc MP documentation system (Bio-Rad). The 
purity of the target protein in the eluate was determined using densitometry.  
 
Table 2.3 Molecular weight, PI, and extinction factor for the constructs 
Sample MW (kDa) Extinction factor (cm-1M-1) * 
T7-GFP-G4S-MPG 33 22515 
MPG-G4S-MPG 30 22515 
T7-6×His-GFP 29.67 22015 
T7-GFP-6×His 30.045 22015 
GFP-6×His 28.14 22015 
*Extinction factors were calculated using Expasy’s ProtParam tool at https://web.expasy.org/protparam/.  
 





To compare the expression level of different constructs, we performed Western 
blotting. A 5 ml overnight culture in LB broth liquid media (10 mg/ml tryptone, 10 
mg/ml NaCl, and 5 mg/ml yeast extract) containing ampicillin was prepared and 
subcultured into 10 mL fresh LB media as described for protein expression (Section 
2.2). After 2.5 h of shaking at 225 RPM and 37 ℃, IPTG (Fisher BioReagents) was 
added to a final concentration of 0.01 mM, and 6 h after the beginning of induction, the 
cells were harvested at 4300 × g and 4 ℃ for 20 mins. The cell pellet was lysed using 
BugBuster Master Mix (EMD Millipore) according to the manufacturer’s protocol to 
extract proteins in the soluble fraction of the cells. In cases where proteins were not 
detected in the soluble fraction, protein in inclusion bodies was recovered according to 
the BugBuster manufacturer’s protocol. The absorbance at 280 nm of the solution 
containing proteins (soluble or insoluble) was measured using a Nanodrop 2000 
Spectrophotometer instrument to estimate the total concentration of proteins in the 
sample.  The same mass of total protein for each sample was loaded onto a gel for 
separation by SDS-PAGE (Section 2.4). After separation by SDS-PAGE, the proteins 
were transferred to a polyvinyl difluoride (PVDF) membrane using the Trans-Blot 
Turbo instrument (Bio-Rad). Then the membrane was blocked by incubation in 5% 
(w/v) non-fat dry milk in Tris-buffered saline containing Tween-20 (TBST; 0.1% 
Tween-20, 50 mM Tris-HCl pH 7.5, 150 mM NaCl) for an hour at room temperature 
or overnight at 4 ℃. After blocking, the membrane was washed three times with TBST. 
We incubated the membrane with appropriate dilutions of the horseradish peroxidase 
(HRP)-conjugated anti-6×His tag antibody (Abcam) and/or HRP-conjugated anti-GFP 





hour at room temperature. After the incubation with antibodies, the membrane was 
washed 6 times with TBST buffer. Clarity Western ECL substrate (Bio-Rad) was added 
to the membrane, and the membrane was incubated for 5 mins. The chemiluminescence 
was imaged on a ChemiDoc MP documentation system to visualize the protein on the 
blot. 
 
2.6 Size exclusion chromatography (SEC) 
To see if the purified protein sample contained soluble aggregates, we performed SEC. 
An Enrich-650 high resolution SEC column (Bio-Rad) was attached to the NGC liquid 
chromatography instrument (Bio-Rad). Phosphate-buffered saline (PBS; 137 mM 
NaCl, 2.7 mM KCL, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.5) was used as the 
mobile phase, and the column was equilibrated with two column volumes (the volume 
of Enrich 650 is 25 mL) of PBS. Before applying the sample, the column was calibrated 
using the gel filtration standard (Bio-Rad) (Table 2.4).  The purified proteins were 
adjusted to the desired concentration and passed through a 0.2 μm filter before applying 
to the column. A volume of 100 μL of samples concentrated to 200 μM were applied 
to the column, and the system was at a flow rate of 1 mL/min in PBS. The absorbance 
at 280 nm was measured at the column exit. ChromLab software (Bio-Rad) was used 
to visualize the data. 
 
Table 2.4 SEC standard proteins and their approximate elution volume. 





Thyroglobulin 670 ̴ 10 
Bovine γ-globulin 158 ̴ 12 
Chicken ovalbumin 44 ̴ 14 
Equine myoglobin 17 ̴ 15.5 
Vitamin B12 1.35 ̴ 18 
 
2.7 Quantification of translocation of GFP into C. albicans cells 
We quantified and compared the translocation of GFP fusions to MPG into C. albicans 
cells using flow cytometry.  
 
2.7.1 C. albicans cell growth and preparation  
The C. albicans SC5314 strain (American Type Culture Collection) was streaked on a 
yeast-peptone-dextrose (YPD) agar plate (1% yeast extract, 2% peptone, 2% glucose, 
and 2% agar) and incubated at 30 ℃ for 24 h. We picked a random colony, inoculated 
it into 5 ml of YPD liquid medium (1% yeast extract, 2% peptone, and 2% glucose), 
and grew the culture overnight at 30 ℃ while shaking at 230 RPM. The overnight 
culture was subcultured into 5 ml of fresh YPD liquid medium to an optical density at 
600 nm of 0.1 and incubated at 30 ℃ while shaking at 230 RPM. When the optical 
density at 600 nm reached 0.5, cells were pelleted by centrifugation at 3900 × g and 
washed 2 times with 10 mM NaPB (pH 7.5). Then cells were resuspended in 10 mM 







2.7.2 Protein preparation for incubation with C. albicans cells 
Each purified protein construct used in the flow cytometry assay was dialyzed against 
10 mM NaPB (pH 7.5) using 10,000 molecular weight cut-off (MWCO) SnakeSkin 
dialysis tubing (Thermo Scientific) overnight at 4 ℃.  The protein solutions were then 
concentrated to the desired concentration for the experiment using 10 kDa sample 
concentrators (Cytiva Vivaspin), according to the manufacturer’s protocol.  
 
2.7.3 Sample incubation and analysis with flow cytometry 
Protein samples (100 μL) at 200 μM or 800 μM, depending on the experiment 
conditions, were added to 100 μL of the cell suspension prepared in Section 2.5.1. The 
samples were incubated at 30 ℃ for 1, 8, and 24 h to allow translocation of the protein 
fusions into the cells. After each incubation time was over, the cells were pelleted by 
centrifugation at 5,000 × g for 10 mins at 4 ℃. The supernatant was discarded, and the 
pellet was washed with 200 μL of 10 mM NaPB (pH 7.5) buffer. To remove any protein 
bound to the surface of cells, we incubated the cells with 200 μL of trypsin (Invitrogen) 
at 37 ℃ for 30 mins, as has been done previously in our lab30,32. After 30 mins, cells 
were pelleted at 5,000 × g for 10 mins at 4 ℃ and washed once with 200 μL of 10 mM 
NaPB (pH 7.5). Cells were resuspended in 200 μL of 10 mM NaPB (pH 7.5) and 
transferred to polystyrene flow cytometry tubes (Corning) to analyze samples for 
translocation of GFP using flow cytometry (BD FACSCantoII). To determine the 





added to a final concentration of 0.1 mg/ml in the samples right before analyzing with 
flow cytometry. Each cell was individually passed through a 488 nm excitation laser 
and 530/30 emission filter, and the emitted light was used to determine the percentage 
of PI- and FITC-positive cells for each sample. The experiment was done on 6 different 
days, and, for each day, a different batch of purified protein was used. On each day, 
two technical replicates were included.   
 
 2.7.4 Statistical analysis  
Statistical analysis was done using GraphPad Prism 9.1.2. Since we had two 
independent variables in our analysis (time and proteins), we used a two-way ANOVA 
method, and Tukey's multiple comparison was performed to compare all the samples 
with one another. The threshold was set to α= 0.05, and the P values were analyzed to 
determine the level of significance in the difference between the samples. A P-value 













Chapter 3: Results and discussion  
3.1 Selection of the CPP and protein cargo  
To study the ability of the CPPs to take molecular cargo into C. 
albicans cells, we selected GFP to serve as our model cargo. GFP, 
with its innate ability to emit green fluorescence, is a perfect 
candidate for tracking internalization of the construct using 
fluorescent microscopy or flow cytometry. GFP is originated from 
bioluminescent jelly fish Aequorea victoria34,35. It contains a p-
hydroxybenzylidene-2-3-dimethylimidazolinone chromophore 
core, which is responsible for the green fluorescence (Figure 3.1). 
This motif is well protected from the outside environment by 
eleven β-sheets and two α-helices35. Wild-type GFP absorbs blue light at 395 nm and 
emits it at 510 nm34. GFP has widely been used in biological research due to ease of 
expression, detection, and high stability. 
 
We selected MPG as our CPP delivery vehicle (Table 2). It is an amphipathic peptide 
consisting of 27 amino acids with a net charge of +3 not including charge from N-
terminal free amine12,23,29. This peptide is a chimeric peptide which has two main 
domains: an N-terminal hydrophobic domain obtained from the fusion sequence of the 
HIV gp41 glycoprotein, and an NLS domain consisting of 6 residues (KKKRKV) 
derived from the SV40 large T-antigen12,38. These two domains are linked together 
with a sequence of 4 amino acids, which provides flexibility and stability for both 
Figure 3.1 Crystal structure of GFP. 
The c- and N- terminal ends as well as 
the central chromophore are marked in 
the picture36. Figure reprinted with 







motifs due to the presence of proline12,32. MPG has been previously studied in our 
lab, and its mechanism of action and translocation into C. albicans cell is 
characterized20,23,27,29.  With that in mind, we found it a good CPP for our study to 
determine the best position for the attachment of the cargo.  
 
3.2 Cloning and design of the construct  
The main purpose of this study was to find the preferred position of cargo with respect 
to the CPP for the highest translocation level into C. albicans cells. We designed a 
construct where GFP is fused to the N-terminus of a CPP (GFP-G4S-CPP) (Figure 
2.1a,b) and compared its translocation to the construct where GFP is fused to the C-
terminus of CPP (CPP-G4S-GFP) (Figure 2.1c), which was made and tested for 
translocation previously in our lab2. Negative controls for the GFP-G4S-CPP fusion 
that lacked the CPP were also made (Figure 2.1a, b), and the previously designed 






Figure 3.2 Schematic overview of designed recombinant proteins with the GFP attached at the N- 
and C-terminus of the CPP. the T7 tag was included to increase expression level, and the factor Xa 
cleavage site was included to remove the T7 tag or 6×His tag if required. There is a sequence coding for 
G4S between GFP and the CPP to provide more flexibility and increase the translocation23.  
 
The bacteriophage T7 epitope (T7 tag) consists of 11 amino acids 
(MASMTGGQQMG), and, when located upstream of the target gene, it can increase 
the recombinant protein expression37. It can also be used as an affinity tag for 
purification and detection of the target protein. A hexahistidine tag (HHHHHH; 6×His 
tag) was fused to the protein for purification and detection purposes38. The advantage 
of the 6×His tag is that it rarely impacts protein function due to its small size and low 
charge37.  A factor Xa cleavage site with the sequence I(E/D)GR was incorporated to 
allow removal of the T7 tag for downstream applications using factor Xa protease, 





unique restriction enzyme sites at both ends of each component, so they are 
exchangeable with one another or with different components for future studies. A 
glycine-serine linker peptide (G4S) was included to improve expression, since it was 
previously found to be effective in increasing the protein expression and helping with 
translocation into C. albicans cells23. 
 
The pET system used in this study is one of the most popular systems for cloning 
recombinant proteins, and it does not express the target recombinant protein until it is 
induced by an appropriate agent, which is very helpful when working with CPPs that 
might be toxic to the cells. The expression strain is BL21(DE3) E. coli, which contains 
the T7 RNA polymerase gene. This gene is regulated by lacUV5 promoter, and once 
induced with, IPTG,), it will promote the transcription and expression of the target 
protein39.  
 
After expressing the GFP-G4S-MPG construct, we ran a Western blot to compare its 
expression with the MPG-G4S-GFP construct, which was shown previously to have a 
high level of expression32 (Figure 3.3a). We did not detect the 6×His tag in the GFP-
G4S-MPG; however, the previously produced MPG-G4S-GFP was detected by the 
antibody in the same blot. This suggested that either the 
 GFP-G4S-MPG fusion protein was not expressed by the cells or the 6×His tag at its N-
terminus was not present or not detectable in this construct (Figure 3.3a). When 
pelleting the MPG-G4S-GFP and GFP-G4S-MPG by centrifugation, we noticed that the 





so we assumed that the issue was expression of the construct. To help select for a colony 
capable of expressing the construct, we modified our protocol to screen the transformed 
cells for the expression of the GFP before assessing the expression of the whole 
construct with Western blotting. We identified multiple GFP-expressing clones 
containing the GFP-G4S-MPG plasmid and performed Western blotting to detect 6×His 
tag and GFP (Figures 3.3b,c). Presence of GFP was confirmed by Western blotting, but 
the 6×His tag was still not detectable. One possible reason for the inability to detect the 
6×His tag is that the protein may have been truncated due to the proteolytic cleavage 
in recombinant protein production.  
 
 
Figure 3.3 Expression of the GFP-G4S-MPG. (a) Blot stained with anti-6xHis antibody with only 
MPG-G4S-GFP construct detected. (b,c) Comparing MPG-G4S-GFP in Lane 1 with three different green 
clones of GFP-G4S-MPG picked from an LB plate containing IPTG (Lanes 2-4). Blot stained with anti-
6xHis (b) and anti-GFP (c). 
 
To determine if this result was specific for MPG or more general, we built two plasmids 





same results observed with the MPG peptide: no 6×His tag was detected, but GFP was 
detected (Figure 3.3a). We noticed two close bands for GPF-G4S-MPG that might be 
due to degradation of the peptide, while the GFP-G4S-MAP and GFP-G4S-pVEC seem 
to be intact with only one band being detected by anti-GFP (Figure 3.4a). This can be 
used to compare the stability of three peptides, indicating that pVEC and MAP are more 
stable than MPG which is consistent with the data found for pVEC in the 
literature40.We do not know why the 6×His tag was not detected at the N-terminus of 
the GFP-G4S-MPG. We decided to add a T7 epitope tag to the N-terminus of the 
construct to help the detection of 6×His tag by using the properties of T7 epitope tag 
which helps increasing expression of recombinant proteins38 (Figure 3.2a). After 
addition of the T7 tag, the Western blot results showed some traces of the presence of 
6×His tag in the T7-GFP-G4S-MPG (Figure 3.4b). However, the levels were still not 
comparable to the MPG-G4S-GFP construct. On the other hand, the anti-GFP results 
were promising and showed the expression of GFP in all the constructs (Figure 3.4b). 
Based on the results from the Western blot, we assumed that 6×His is not detectable by 
the Western blot, and we decided to test whether we could purify the construct by 
IMAC using Ni-charged resins. The purification was successful, showing that the 
6×His tag was present and accessible for attachment to the Ni-charged resins. We will 








Figure 3.4 Expression of GFP-G4S-MAP, GFP-G4S-pVEC, and T7-GFP-G4S-MPG. (a)  
Expression of plasmids containing GFP-G4S-CPP compared to MPG-G4S-GFP with anti-6xHis and anti-
GFP antibodies. (b) Expression of GFP-G4S-MPG is increased when T7-tag was fused to the N-terminus 
of the construct.  
 
The expression of recombinant proteins containing CPPs can be challenging32, like 
having unacceptable degradation or expression of protein in inclusion body. In the case 





previous high expression level of MPG-G4S-GFP32. GFP is well produced and well 
folded in E. coli42 and can function as a soluble expression partner, so moving it to the 
N-terminus was expected to improve expression. Our observation that the expression 
of both constructs, the GFP-G4S-MPG and T7- GFP-G4S-MPG was lower than the 
MPG-G4S-GFP, highlights the difficulties in expressing CPP fusions and the lack of a 
defined protocol for their expression. More research to understand the exact behavior 
of CPPs when they are fused to other proteins is needed.  
 
3.3 Purification and protein characterization 
In this part of the work our main purpose was to purify the recombinant proteins and 
prepare them for the translocation study.  
 
3.3.1 Purification results 
Our proteins contained the 6×His tag, which has affinity to metal ions like Ni2+, Zn2+, 
and Cu2+39. The proteins were purified using Ni-charged IMAC resins under native 
(non-reducing) conditions. We collected samples from wash and elution steps and 
analyzed them on an SDS-PAGE gel to see what sizes of protein each sample contained 
and determine the purity of the desired protein construct (Figure 3.5). The SDS-PAGE 
was analyzed with densitometry to determine the purity of the proteins (Table 3.1). All 
proteins showed almost 99% purity, except for T7-GFP-G4S-MPG. T7-GFP-G4S-MPG 





Western blots, as well (Figure 3.4a), and we assume that the lower band is a degradation 
product of T7-GFP-G4S-MPG. 
 
 
Figure 3.5 Representative SDS-PAGE result for all the constructs used in this study. The eluate (E) 
and the wash (W2) were separated by SDS-PAGE and stained with Coomassie stain. The lowest purity 
belongs to GFP-G4S-MPG. The blue arrows show the desired size in the eluate of each sample. The red 
arrows show shared impurity between T7-GFP-G4S-MPG and MPG-G4S-GFP. 
 
Table 3.1 The purity of the constructs after one step of IMAC purification.  
Protein construct Purity 
T7-GFP-G4S-MPG 52% 
T7-6×His-GFP ̴ 99% 
T7-GFP-6×His ̴ 99% 
MPG-G4S-GFP ̴ 99% 






When washing with 10 mM imidazole to remove loosely bound proteins, we noticed 
that the samples collected from this wash (W2) were green for most proteins, indicating 
the early elution of GFP. After analysis of the wash samples with SDS-PAGE, we 
observed that a portion of target protein was the most abundant protein eluted in the 
wash for most proteins, with the exception being MPG-G4S-GFP where other 
impurities were eluted (Figure 3.5). For the other samples, the washing solution did not 
remove a substantial amount of impurity but did remove the desired protein. Because 
of this, for the rest of our experiments, we eliminated washing with 10 mM imidazole 
for every protein except for MPG-G4S-GFP. 
 
3.3.2 SEC results 
SEC was performed on T7-GFP-G4S-MPG, MPG-G4S-GFP, and T7-6×His-GFP to 
visualize the presence of soluble aggregates in the purified protein samples. T7-6×His-
GFP showed only one peak at around a volume of 15 mL (Figure 3.6a), which, 
according to the column calibration, is at the volume we expect for the elution of a 
protein the size of T7-6×His-GFP (30 kDa). These results suggest T7-6×His-GFP does 
not form soluble aggregates. On the other hand, T7-GFP-G4S-MPG (33 kDa) (Figure 
3.6b) and MPG-G4S-GFP (30 kDa) (Figure 3.6c) both showed a peak at a volume of 
9.2 mL, in addition to the primary peak at the size expected for monomeric versions of 
these constructs. The peak at 9.2 mL represents a size of around 700 kDa, which is very 
large compared to the size of both constructs. The fusion of peptides to GFP can lead 
to aggregate formation43, and, since we did not observe a peak eluting at the same 





very large soluble aggregates containing nearly 30 monomeric proteins. We compared 
the relative area under the aggregate peak to the relative area under the peak 
representing the desired proteins (T7-GFP-G4S-MPG and MPG-G4S-GFP), and we 
found a higher relative amount of aggregated protein in the T7-GFP-G4S-MPG protein 
sample (13% aggregated) than in the MPG-G4S-GFP protein sample (2% 
aggregated).This suggests that the relative position of the CPP and GFP influences 
































a)    T7-6×His-GFP 
15 mL 








Figure 3.6 SEC results for (a) T7-6×His-GFP, (b) T7-GFP-G4S-MPG, and (c) MPG-G4S-GFP. The 
purified proteins were concentrated to 200 mM total protein concentration (purity of construct was not 
considered) and run on an SEC column to look for soluble aggregate formation. Protein concentration 
eluted in the volume fractions is proportional to UV absorbance at 280 nm. The red arrows indicate the 
volume where the peaks appear. The black arrows mark the elution volume of the standards and the 







































































Just before the peak corresponding to monomeric protein for T7-GFP-G4S-MPG and 
MPG-G4S-GFP (at a volume of around 15 mL), we observed a slight increase of 
absorbance at a volume of 13.7 mL. This increase was consistently repeated in all our 
experiments with T7-GFP-G4S-MPG and MPG-G4S-GFP but not with T7-6×His-GFP. 
This peak falls between 158 kDa and 44 kDa (red arrows on the Figures 3.4b and 3.4c) 
and could represent an impurity in the purified protein samples that corresponds to a 
protein with a size of about 75 kDa. The impurity can be seen on the SDS-PAGE results 
for T7-GFP-G4S-MPG and MPG-G4S-GFP (Figure 3.5), but the band is faint for MGP-
G4S-GFP. Another possibility for this peak is that it indicates some smaller soluble 
aggregates in these samples, with each aggregate containing around 3 monomers.  
 
The results from SEC, indicating that our proteins are forming aggregates, is 
consistent with the results from a previous study on MPG-G4S-GFP with dynamic 
light scattering (DLS)29. We do not know what effect aggregation has on the 
interaction of the MPG with GFP and the constructs with C. albicans cells or their 
translocation into cells, but this would be an interesting topic for further research. 
 
3.4 Effect of T7 tag on the translocation of cargo without CPP 
As discussed in Section 3.2, we found the T7 tag improved the expression of the T7-
GFP-G4S-MPG construct compared to the construct without the T7 tag. To determine 
whether the T7 tag affects translocation into C. albicans cells, we compared 





presence of GFP in cells following incubation with the proteins for 1, 8, and 24 h. 
Following washing and treating with trypsin to remove protein attached to the surface 
of the cells, we performed flow cytometry to measure the fluorescence of the cells to 
detect intracellular GFP. To quantify the membrane permeabilization, we added PI to 
each sample immediately before analysis with flow cytometry. GFP-6×His has been 
tested for translocation previously in our lab, and it showed a low, but measurable, level 
of translocation into C. albicans, even though it contains no CPP 30. 
 
 
 Figure 3.7 Translocation of T7-GFP-6×His and GFP-6×His into C. albicans cells. Flow cytometry 
was used to measure translocation of cargo into C. albicans cells. Multiple replicates of the experiment 





to the sample prior to analysis with flow cytometry to determine the membrane permeabilization. The 
dot plots are for (a) cells incubated with buffer only, (b) cells incubated with methanol, (c) cells incubated 
with GFP-6×His, and (d) cells incubated with T7-GFP-6×His. The quadrant Q1 represents cells that do 
not contain GFP (GFP-) but have PI translocated in the cells (PI+), Q2 represents cells with both GFP+ 
and PI+ (GFP+/PI+), Q3 contains the intact cells with no PI and no GFP inside (GFP-/PI-), and Q4 
represents cells with GFP+ only (GFP+/PI-). The number in each quadrant represents the percentage of 
cells falling in that quadrant, and each dot in the plots represents a single cell.  
  
Flow cytometry was used to measure the GFP fluorescence and PI fluorescence of each 
cell (Figure 3.7). To quantify the translocation of the T7-GFP-6×His and GFP-6×His, 
we used the data from the dot plots to determine the percentage of all cells in each 
sample containing GFP. The percentage of GFP-positive cells includes the cells from 
quadrant Q4 (GFP+/PI-) and quadrant Q2 (GFP+/PI-) in the dot plots (Figure 3.7).   



























Figure 3.8 Impact of T7 tag at the N-terminus of GFP (without CPP) on the translocation into C. 





of cells containing GFP fluorescence was determined by flow cytometry. The experiment included 6 
replicates (three biological replicates each containing two technical replicates). The error bars represent 
the standard error of the mean. Brackets indicate the statistical significance of pairs of samples (ns: not 
significant). 
 
As shown in Figure 3.8, the difference in translocation between the constructs with and 
without the T7 tag was not statistically significant, so we concluded that the presence 
of the T7 tag does not affect translocation. With that in mind, subsequent experiments 
with the CPP at the C-terminus of GFP included the T7 tag in the protein fusion 
constructs, since the T7 tag improved the expression of the construct containing the 
CPP (Section 3.1). Our protein fusion design does include a factor Xa cleavage site to 
remove the T7 tag, if desired for future applications.  
 
3.4 Effect of CPP attachment location on the translocation of cargo 
There are two orientations possible for the fusion of CPP to the cargo: CPP-cargo or 
cargo-CPP. Each of these orientations might affect the interaction between the CPP and 
cargo, as well as the interaction of the whole construct with the cell membrane. We 
designed fusions with both orientations to determine the effect of orientation on 
translocation. The constructs MPG-G4S-GFP and T7-GFP-G4S-MPG, along with 
negative controls lacking a CPP, were incubated with C. albicans for 1, 8, and 24 h and 







Figure 3.9 Translocation of GFP into C. albicans cells. Flow cytometry data are graphed for the 
translocation of MPG-G4S-GFP, T7-GFP-G4S-MPG, 6×His-GFP, and GFP-6×His into cells following 
incubation with the cells for the indicated time. (a) The percentage of GFP-positive cells represents the 
mean of cells that are PI+/GFP+ and PI-/GFP+ (flow cytometry dot plot quadrants Q2 and Q4 in Figure 
3.7) for a total of 8 replicates. (b) The percentage of PI-positive cells represents cells that are PI+/GFP+ 
only (Q2 in Figure 3.7) of the same 8 replicates represented in (a). The error bars represent standard error 
of the mean. Asterisks on the brackets indicate the significance level for the indicated sets of data (ns= 
not significant, *=P<0.05, ** =P<0.01; ***= P<0.001, and ****= P<0.0001). 
 
Based on the data in Figure 3.9.a, both negative control GFP constructs without a CPP 
(T7-6×His-GFP and GFP-6×His) translocate into the C. albicans cells; however, their 
translocation is not significant, and this is consistent with previous analyses in our lab 
on the translocation of GFP constructs lacking a CPP into C. albicans23,29. 
 
MPG-G4S-GFP does translocate into C. albicans cells at levels above the negative 
control, and we observed a significantly higher translocation of the MPG-G4S-GFP into 





in the previous study in our lab, as well29. The translocation of MPG-G4S-GFP 
following incubation with cells for 24 h varied widely in our experiments, ranging from 
0.9 to 8.6 % of cells having GFP translocated inside in the data plotted in Figure 3.9. 
Once during our experiments, we observed a translocation of 65%, increasing the 
overall average translocation of MPG-G4S-GFP to almost 10% (see Appendix A, 
Figure A.2); however, since this high level of translocation was an order of magnitude 
higher than our other results and not repeated in our experiments, we did not include 
this set of data in Figure 3.9 or in associated statistical analyses. Although we observed 
high translocation with MPG-G4S-GFP only once in our experiments, similarly high 
levels of translocation of MPG-G4S-GFP have previously been observed in our lab
30. 
With that in mind, the results from the translocation assay support the hypothesis that 
MPG-G4S-GFP does carry large cargos inside the cells, but the translocation level can 
vary widely, and more research is required to obtain a high and reproducible 
translocation of MPG-G4S-MPG into the C. albicans cells. 
 
When changing the position of the cargo from the C-terminus of the CPP (MPG-G4S-
GFP) to its N-terminus (T7-GFP-G4S-MPG), we noticed a significant reduction in 
translocation (Figure 3.9a). In fact, no significant translocation of the T7-GFP-G4S-
MPG compared to the control T7-6×His-GFP was observed after 1 and 8 h of 
incubation, and the negative control was significantly higher than T7-GFP-G4S-MPG 
after incubation for 24 h (Figure 3.9a). This observation is supported by the simulation 
study on the translocation of MPG without cargo, which was done by Dr. Jeffery 





membrane with its N-terminal end initiating the insertion29,31. This is consistent with 
the observation of MPG-G4S-GFP translocating into the cells at levels significantly 
higher than T7-GFP-G4S-MPG. In the construct T7-GFP-G4S-MPG, the part of CPP 
that is responsible for interaction with the cell membrane is attached to GFP and may 
not be able to initiate the membrane insertion required for translocation.   
 
In addition to considering the translocation of GFP, we also considered the permeability 
of the cells by evaluating uptake of PI (Figure 3.9b), which only enters cells with 
damaged membranes, in the cells containing GFP (GFP+/PI+) (Figure 3.9b). During 
all the experiments, we observed both intact cells containing GFP (GFP+, PI-) and 
permeabilized cells with translocated GFP (GFP+, PI). The permeabilization of the 
cells may be a result of pore formation by the MPG and the cells failing to repair the 
pore. It may also be due to cell death, unrelated to translocation of the CPPs, since we 
observed 15% of dead cells that were permeable to PI in the flow cytometry results 
from cells incubating in buffer only (Figure 3.7a). Based on these data, we cannot 
conclude that translocation of MPG-G4S-GFP into the cells leads to membrane 
disruption and subsequently cell death, but it is possible that they have some toxicity 
toward the cell, which would be beneficial for antifungal applications of our work.  
 
3.6 The effect of protein concentration on translocation 
To see if increasing the concentration of protein results in enhanced translocation for 
MPG-G4S-GFP, we compared two protein concentrations during translocation: 100 μM 





consideration; see Section 2.7.) We incubated the constructs with the C. albicans cells 
for 1 and 24 h before performing flow cytometry.  
 



































Figure 3.10 Effect of protein concentration on the translocation into fungal cells. Flow cytometry 
data from 3 replicates that were carried out on 3 different days using 3 different batches of purified 
proteins are plotted. The percentage of GFP-positive cells considers both GFP+/PI+ and GFP+/ PI- cells. 
The error bars represent the standard error of the mean.  
 
Increasing the protein concentration from 100 μM to 400 μM had no statistically 
significant effect on the translocation of the constructs into C. albicans cells (Figure 
3.10). We observed that both concentrations show significantly higher translocation at 
24 h compared to 1h. However, the level of significance for the proteins at 100 μM is 





CPPs, which found that increasing concentration above 100 μM does not help MPG 


























Chapter 4: Conclusion and future work 
4.1 Conclusion 
 In this study, we evaluated the effect of the position of GFP, which represents a cargo 
attached to a CPP, on the ability of MPG to translocate and carry the cargo inside C. 
albicans cells. We found that the position of the cargo has a significant effect on the 
translocation of the whole construct, with GFP fused to the C-terminus of the MPG 
being the optimum position for the cargo. When the GFP was fused to the N-terminus, 
little to no translocation was detected, likely because the peptide requires the N-
terminal residues for interaction with the cell membrane. We learned that CPPs can 
carry a large cargo like GFP into C. albicans cells, but our results with the MPG peptide 
shows a large variation in the translocation rate of the CPP-cargo fusion, indicating 
that, despite the ability of this CPP to take the cargo into the C. albicans cells, more 
work is needed to achieve robust translocation results.  
 
4.2 Future work 
The variations observed in the translocation of MPG in this thesis and previous work 
in our lab27,29 emphasize the need for more research on improving translocation 
efficacy of CPP-fusion constructs. Below, we describe possible alternative CPPs and 
CPP formats, along with a suggested study to better understand degradation products 





4.2.1 Substitution of MPG with pVEC and SynB 
In the previous studies in our lab, pVEC, MAP, and SynB showed that they can carry 
a fluorescent label into almost 100% of C. albicans cells27, but they have not been 
tested for larger cargoes like GFP. MAP and pVEC did show toxicity towards C. 
albicans cell, but a previous study has shown that the toxicity can be reduced by 
reduction in the hydrophobicity of the peptide26. One possible future experiment for 
improving delivery of cargo to the C. albicans cells is changing MPG to pVEC, SynB, 
and/or MAP to evaluate their translocation into the cells. Based on the toxicity data, 
manipulation of MAP and pVEC via rational design might be required if low levels of 
toxicity are desirable26. According to previous studies, if the cargo is attached to the 
appropriate end of the CPPs, we may see much higher translocation with these CPPs 
than what we observed with MPG.  
 
4.2.2 Cyclization of MPG 
Cyclization of CPPs has been reported to help the delivery of enhanced GFP (eGFP) 
directly into the cytosol of the mammalian cells27. The addition of two cysteine residues 
at appropriate locations of the MPG will promote the formation of a disulfide bond 
between the cysteines and create a cyclized MPC (cMPG) (Figure 4.1). Considering 
the results from simulations and experiments showing that the N-terminus of MPG 
plays a major role in the penetration of the peptide across the cell membrane, we need 
to consider the design in a way that the N-terminal end is free. Cyclization of peptides 





residues45. In order to keep the N-terminal end free, we need to add a free cysteine 
residue at the C-terminus and one in the middle of the MPG. Since we do not know 
how many amino acids are required for internalization of the constructs at the N-
terminus, we propose the creation of an initial library of cMPGs through rational design 
by a cysteine residue at various locations of the MPG (Table 4.1). The charged residues 
are located at the C-terminal end (KKKRKV) and a sequence of amino acids (WSQP) 
links hydrophobic and hydrophilic domains, so our initial library cyclizes the charged 
residues including the linker (cMPG1).  Based on the results with the initial library, 
additional locations for cysteines could be evaluated to find the optimal location.  
 
 
Figure 4.1 Schematic representation of (a) cMPG-G4S-GFP and (b) MPG-G4S-GFP 
 
Table 4.1 Suggested library of cMPGs 















Simulations can be incorporated to choose the most promising cMPGs from the library, 
and then, after expression and purification of the desired cMPG-G4S-GFP proteins, we 
can compare translocation into C. albicans cells with the linear MPG-G4S-GFP 
experimentally to see whether cyclization will improve the translocation efficiency and 
reproducibility. Additionally, the cyclization of the CPP might increase the stability of 




4.2.3 Identification of degradation product 
As was discussed in Sections 3.1 and 3.2, we observed a degradation product on the 
SDS-PAGE gel in the T7-GFP-G4S-MPG purified sample (Figure 3.5). Although we 
considered the purity of the T7-GFP-G4S-MPG in our experiments (assuming the larger 
band represented full-length protein), the presence of the degradation product suggests 
the construct is not completely proteolytically stable, introducing the possibility that 
even what we thought was full-length protein may not have all the amino acids for 
MPG. The characterization of both the “full-length” protein and degradation product 
by mass spectrometry will give validity to the results of this study. We observed little 
to no level of translocation of the T7-GFP-G4S-MPG into the cells but knowing that 








Figure A.1 Flow cytometry data for one replicate after 24 h incubation with C. albicans. Flow 
cytometry was used to get the data for translocation of cargo into the C. albicans cells. Multiple replicates 
of the experiment have been done, and these data are representative of samples after incubation for 24 h 
with cells. PI was added to the sample prior to analysis with flow cytometry to determine the membrane 
permeabilization. The dot plots are for (a) cells incubated with buffer only, (b) cells incubated with 
methanol, (c) cells incubated with GFP-6×His, (d) cells incubated with 6×His-GFP, (e) cells incubated 
with MPG-G4S-GFP, and (f) cells incubated with T7-GFP-G4S-MPG. The quadrant Q1 represents cells 
that do not contain GFP (GFP-) but have PI translocated in the cells (PI+), Q2 represents cells with both 
GFP+ and PI+ (GFP+/PI+), Q3 contains the intact cell with no PI and no GFP inside (GFP-/PI-), and Q4 
represents cells with GFP+ only (GFP+/PI-). The number in each quadrant represents the percentage of 































Figure A.2 The average translocation of constructs into C. albicans cells including replicate with 
very high translocation. Flow cytometry data are graphed for MPG-G4S-GFP, T7-GFP-G4S-MPG, 
6×His-GFP, and GFP-6×His. Following incubation with the cells for the indicated time, the percentage 
of GFP-positive cells represents the mean of cells that are PI+/GFP+ and PI-/GFP+ (flow cytometry dot 
plot quadrants Q2 and Q4 in Figure A2) for a total of 9 replicates. The replicate showing a high level of 


















Table B. 1. Statistical analysis for impact of T7 tag at the N-terminus of GFP (without CPP) on the 
translocation into C. albicans (Figure 3.8) 
Tukey's multiple comparisons test Mean 
difference 




1 hr: T7-GFP-6×His vs. 1 hr: GFP-6×His -0.025 -0.6071 to 0.5571 ns >0.9999 
1 hr: T7-GFP-6×His vs. 8 hr: T7-GFP-
6×His 
0.0125 -0.5696 to 0.5946 ns >0.9999 
1 hr: T7-GFP-6×His vs. 8 hr: GFP-6×His -0.1875 -0.7696 to 0.3946 ns 0.9274 
1 hr: T7-GFP-6×His vs. 24 hr: T7-GFP-
6×His 
-0.2625 -0.8446 to 0.3196 ns 0.7578 
1 hr: T7-GFP-6×His vs. 24 hr: GFP-6×His -0.5125 -1.095 to 0.06959 ns 0.1128 
1 hr: GFP-6×His vs. 8 hr: T7-GFP-6×His 0.0375 -0.5446 to 0.6196 ns >0.9999 
1 hr: GFP-6×His vs. 8 hr: GFP-6×His -0.1625 -0.7446 to 0.4196 ns 0.9595 
1 hr: GFP-6×His vs. 24 hr: T7-GFP-6×His -0.2375 -0.8196 to 0.3446 ns 0.8256 
1 hr: GFP-6×His vs. 24 hr: GFP-6×His -0.4875 -1.070 to 0.09459 ns 0.1473 
8 hr: T7-GFP-6×His vs. 8 hr: GFP-6×His -0.2 -0.7821 to 0.3821 ns 0.9066 
8 hr: T7-GFP-6×His vs. 24 hr: T7-GFP-
6×His 
-0.275 -0.8571 to 0.3071 ns 0.7207 
8 hr: T7-GFP-6×His vs. 24 hr: GFP-6×His -0.525 -1.107 to 0.05709 ns 0.0981 
8 hr: GFP-6×His vs. 24 hr: T7-GFP-6×His -0.075 -0.6571 to 0.5071 ns 0.9988 
8 hr: GFP-6×His vs. 24 hr: GFP-6×His -0.325 -0.9071 to 0.2571 ns 0.5606 























Table B. 2. Statistical analysis for translocation of GFP into C. albicans cells. T. The percentage of 
GFP-positive cells represents the mean of cells that are PI+/GFP+ and PI-/GFP+. (Figure 3.9a).  
 
Tukey's multiple comparisons test Mean 
difference 




1 h: T7-6×His-GFP vs. 1 h: GFP-6×His -0.08889 -1.403 to 1.225 ns >0.9999 
1 h: T7-6×His-GFP vs. 1 h: T7-GFP-G4S-MPG 0.07778 -1.237 to 1.392 ns >0.9999 
1 h: T7-6×His-GFP vs. 1 h: MPG-G4S-GFP -0.5222 -1.837 to 
0.7921 
ns 0.9728 
1 h: T7-6×His-GFP vs. 8 h: T7-6×His-GFP -0.04444 -1.359 to 1.270 ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: GFP-6×His -0.2667 -1.581 to 1.048 ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: T7-GFP-G4S-MPG 0.04444 -1.270 to 1.359 ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: MPG-G4S-GFP -0.7778 -2.092 to 
0.5365 
ns 0.7034 
1 h: T7-6×His-GFP vs. 24 h: T7-6×His-GFP -0.8 -2.114 to 
0.5143 
ns 0.6655 
1 h: T7-6×His-GFP vs. 24 h: GFP-6×His -0.4 -1.714 to 
0.9143 
ns 0.9969 
1 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
-0.04444 -1.359 to 1.270 ns >0.9999 
1 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -2.776 -4.131 to -
1.422 
**** <0.0001 
1 h: GFP-6×His vs. 1 h: T7-GFP-G4S-MPG 0.1667 -1.148 to 1.481 ns >0.9999 
1 h: GFP-6×His vs. 1 h: MPG-G4S-GFP -0.4333 -1.748 to 
0.8810 
ns 0.9938 
1 h: GFP-6×His vs. 8 h: T7-6×His-GFP 0.04444 -1.270 to 1.359 ns >0.9999 
1 h: GFP-6×His vs. 8 h: GFP-6×His -0.1778 -1.492 to 1.137 ns >0.9999 
1 h: GFP-6×His vs. 8 h: T7-GFP-G4S-MPG 0.1333 -1.181 to 1.448 ns >0.9999 
1 h: GFP-6×His vs. 8 h: MPG-G4S-GFP -0.6889 -2.003 to 
0.6254 
ns 0.8367 
1 h: GFP-6×His vs. 24 h: T7-6×His-GFP -0.7111 -2.025 to 
0.6032 
ns 0.8068 
1 h: GFP-6×His vs. 24 h: GFP-6×His -0.3111 -1.625 to 1.003 ns 0.9997 
1 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG 0.04444 -1.270 to 1.359 ns >0.9999 
1 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -2.688 -4.042 to -
1.333 
**** <0.0001 
1 h: T7-GFP-G4S-MPG vs. 1 h: MPG-G4S-
GFP 
-0.6 -1.914 to 
0.7143 
ns 0.9284 
1 h: T7-GFP-G4S-MPG vs. 8 h: T7-6×His-GFP -0.1222 -1.437 to 1.192 ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 8 h: GFP-6×His -0.3444 -1.659 to 
0.9699 
ns 0.9992 
1 h: T7-GFP-G4S-MPG vs. 8 h: T7-GFP-G4S-
MPG 
-0.03333 -1.348 to 1.281 ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 8 h: MPG-G4S-
GFP 
-0.8556 -2.170 to 
0.4588 
ns 0.567 
1 h: T7-GFP-G4S-MPG vs. 24 h: T7-6×His-
GFP 







1 h: T7-GFP-G4S-MPG vs. 24 h: GFP-6×His -0.4778 -1.792 to 
0.8365 
ns 0.9862 
1 h: T7-GFP-G4S-MPG vs. 24 h: T7-GFP-G4S-
MPG 
-0.1222 -1.437 to 1.192 ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 
-2.854 -4.209 to -
1.499 
**** <0.0001 
1 h: MPG-G4S-GFP vs. 8 h: T7-6×His-GFP 0.4778 -0.8365 to 
1.792 
ns 0.9862 
1 h: MPG-G4S-GFP vs. 8 h: GFP-6×His 0.2556 -1.059 to 1.570 ns >0.9999 
1 h: MPG-G4S-GFP vs. 8 h: T7-GFP-G4S-
MPG 
0.5667 -0.7477 to 
1.881 
ns 0.9512 
1 h: MPG-G4S-GFP vs. 8 h: MPG-G4S-GFP -0.2556 -1.570 to 1.059 ns >0.9999 
1 h: MPG-G4S-GFP vs. 24 h: T7-6×His-GFP -0.2778 -1.592 to 1.037 ns 0.9999 
1 h: MPG-G4S-GFP vs. 24 h: GFP-6×His 0.1222 -1.192 to 1.437 ns >0.9999 
1 h: MPG-G4S-GFP vs. 24 h: T7-GFP-G4S-
MPG 
0.4778 -0.8365 to 
1.792 
ns 0.9862 
1 h: MPG-G4S-GFP vs. 24 h: MPG-G4S-GFP -2.254 -3.609 to -
0.8994 
**** <0.0001 
8 h: T7-6×His-GFP vs. 8 h: GFP-6×His -0.2222 -1.537 to 1.092 ns >0.9999 
8 h: T7-6×His-GFP vs. 8 h: T7-GFP-G4S-MPG 0.08889 -1.225 to 1.403 ns >0.9999 
8 h: T7-6×His-GFP vs. 8 h: MPG-G4S-GFP -0.7333 -2.048 to 
0.5810 
ns 0.7744 
8 h: T7-6×His-GFP vs. 24 h: T7-6×His-GFP -0.7556 -2.070 to 
0.5588 
ns 0.7399 
8 h: T7-6×His-GFP vs. 24 h: GFP-6×His -0.3556 -1.670 to 
0.9588 
ns 0.9989 
8 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
2.78E-16 -1.314 to 1.314 ns >0.9999 
8 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -2.732 -4.087 to -
1.377 
**** <0.0001 
8 h: GFP-6×His vs. 8 h: T7-GFP-G4S-MPG 0.3111 -1.003 to 1.625 ns 0.9997 
8 h: GFP-6×His vs. 8 h: MPG-G4S-GFP -0.5111 -1.825 to 
0.8032 
ns 0.9768 
8 h: GFP-6×His vs. 24 h: T7-6×His-GFP -0.5333 -1.848 to 
0.7810 
ns 0.9682 
8 h: GFP-6×His vs. 24 h: GFP-6×His -0.1333 -1.448 to 1.181 ns >0.9999 
8 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG 0.2222 -1.092 to 1.537 ns >0.9999 
8 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -2.51 -3.864 to -
1.155 
**** <0.0001 
8 h: T7-GFP-G4S-MPG vs. 8 h: MPG-G4S-
GFP 
-0.8222 -2.137 to 
0.4921 
ns 0.6265 
8 h: T7-GFP-G4S-MPG vs. 24 h: T7-6×His-
GFP 
-0.8444 -2.159 to 
0.4699 
ns 0.5869 
8 h: T7-GFP-G4S-MPG vs. 24 h: GFP-6×His -0.4444 -1.759 to 
0.8699 
ns 0.9923 
8 h: T7-GFP-G4S-MPG vs. 24 h: T7-GFP-G4S-
MPG 
-0.08889 -1.403 to 1.225 ns >0.9999 
8 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 
-2.821 -4.176 to -
1.466 
**** <0.0001 





8 h: MPG-G4S-GFP vs. 24 h: GFP-6×His 0.3778 -0.9365 to 
1.692 
ns 0.9981 
8 h: MPG-G4S-GFP vs. 24 h: T7-GFP-G4S-
MPG 
0.7333 -0.5810 to 
2.048 
ns 0.7744 
8 h: MPG-G4S-GFP vs. 24 h: MPG-G4S-GFP -1.999 -3.353 to -
0.6438 
*** 0.0002 
24 h: T7-6×His-GFP vs. 24 h: GFP-6×His 0.4 -0.9143 to 
1.714 
ns 0.9969 
24 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
0.7556 -0.5588 to 
2.070 
ns 0.7399 
24 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -1.976 -3.331 to -
0.6216 
*** 0.0002 
24 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG 0.3556 -0.9588 to 
1.670 
ns 0.9989 
24 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -2.376 -3.731 to -
1.022 
**** <0.0001 
24 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 

























Table B. 3. Statistical analysis for translocation of GFP into C. albicans cells. The percentage of 
PI-positive cells represents cells that are PI+/GFP+ only (Figure 3.9b) 
Tukey's multiple comparisons test Mean 
difference 




1 h: T7-6×His-GFP vs. 1 h: GFP-6×His -0.01111 -0.9333 to 
0.9110 
ns >0.9999 
1 h: T7-6×His-GFP vs. 1 h: T7-GFP-G4S-MPG 0.06667 -0.8555 to 
0.9888 
ns >0.9999 
1 h: T7-6×His-GFP vs. 1 h: MPG-G4S-GFP -0.1222 -1.044 to 
0.7999 
ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: T7-6×His-GFP -0.06667 -0.9888 to 
0.8555 
ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: GFP-6×His -0.07778 -0.9999 to 
0.8444 
ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: T7-GFP-G4S-MPG 0.04444 -0.8777 to 
0.9666 
ns >0.9999 
1 h: T7-6×His-GFP vs. 8 h: MPG-G4S-GFP -0.3222 -1.244 to 
0.5999 
ns 0.99 
1 h: T7-6×His-GFP vs. 24 h: T7-6×His-GFP -0.8444 -1.767 to 
0.07770 
ns 0.1056 
1 h: T7-6×His-GFP vs. 24 h: GFP-6×His -0.2444 -1.167 to 
0.6777 
ns 0.9991 
1 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
-0.1333 -1.055 to 
0.7888 
ns >0.9999 
1 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -2.011 -2.933 to -1.089 **** <0.0001 
1 h: GFP-6×His vs. 1 h: T7-GFP-G4S-MPG 0.07778 -0.8444 to 
0.9999 
ns >0.9999 
1 h: GFP-6×His vs. 1 h: MPG-G4S-GFP -0.1111 -1.033 to 
0.8110 
ns >0.9999 
1 h: GFP-6×His vs. 8 h: T7-6×His-GFP -0.05556 -0.9777 to 
0.8666 
ns >0.9999 
1 h: GFP-6×His vs. 8 h: GFP-6×His -0.06667 -0.9888 to 
0.8555 
ns >0.9999 
1 h: GFP-6×His vs. 8 h: T7-GFP-G4S-MPG 0.05556 -0.8666 to 
0.9777 
ns >0.9999 
1 h: GFP-6×His vs. 8 h: MPG-G4S-GFP -0.3111 -1.233 to 
0.6110 
ns 0.9925 
1 h: GFP-6×His vs. 24 h: T7-6×His-GFP -0.8333 -1.755 to 
0.08881 
ns 0.1167 
1 h: GFP-6×His vs. 24 h: GFP-6×His -0.2333 -1.155 to 
0.6888 
ns 0.9994 
1 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG -0.1222 -1.044 to 
0.7999 
ns >0.9999 
1 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -2 -2.922 to -1.078 **** <0.0001 
1 h: T7-GFP-G4S-MPG vs. 1 h: MPG-G4S-
GFP 
-0.1889 -1.111 to 
0.7333 
ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 8 h: T7-6×His-GFP -0.1333 -1.055 to 
0.7888 
ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 8 h: GFP-6×His -0.1444 -1.067 to 
0.7777 
ns >0.9999 
1 h: T7-GFP-G4S-MPG vs. 8 h: T7-GFP-G4S-
MPG 







1 h: T7-GFP-G4S-MPG vs. 8 h: MPG-G4S-
GFP 
-0.3889 -1.311 to 
0.5333 
ns 0.9582 
1 h: T7-GFP-G4S-MPG vs. 24 h: T7-6×His-
GFP 
-0.9111 -1.833 to 
0.01103 
ns 0.0559 
1 h: T7-GFP-G4S-MPG vs. 24 h: GFP-6×His -0.3111 -1.233 to 
0.6110 
ns 0.9925 
1 h: T7-GFP-G4S-MPG vs. 24 h: T7-GFP-G4S-
MPG 
-0.2 -1.122 to 
0.7221 
ns 0.9999 
1 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 
-2.078 -3.000 to -1.156 **** <0.0001 
1 h: MPG-G4S-GFP vs. 8 h: T7-6×His-GFP 0.05556 -0.8666 to 
0.9777 
ns >0.9999 
1 h: MPG-G4S-GFP vs. 8 h: GFP-6×His 0.04444 -0.8777 to 
0.9666 
ns >0.9999 
1 h: MPG-G4S-GFP vs. 8 h: T7-GFP-G4S-
MPG 
0.1667 -0.7555 to 
1.089 
ns >0.9999 
1 h: MPG-G4S-GFP vs. 8 h: MPG-G4S-GFP -0.2 -1.122 to 
0.7221 
ns 0.9999 
1 h: MPG-G4S-GFP vs. 24 h: T7-6×His-GFP -0.7222 -1.644 to 
0.1999 
ns 0.2816 
1 h: MPG-G4S-GFP vs. 24 h: GFP-6×His -0.1222 -1.044 to 
0.7999 
ns >0.9999 
1 h: MPG-G4S-GFP vs. 24 h: T7-GFP-G4S-
MPG 
-0.01111 -0.9333 to 
0.9110 
ns >0.9999 
1 h: MPG-G4S-GFP vs. 24 h: MPG-G4S-GFP -1.889 -2.811 to -
0.9667 
**** <0.0001 
8 h: T7-6×His-GFP vs. 8 h: GFP-6×His -0.01111 -0.9333 to 
0.9110 
ns >0.9999 
8 h: T7-6×His-GFP vs. 8 h: T7-GFP-G4S-MPG 0.1111 -0.8110 to 
1.033 
ns >0.9999 
8 h: T7-6×His-GFP vs. 8 h: MPG-G4S-GFP -0.2556 -1.178 to 
0.6666 
ns 0.9987 
8 h: T7-6×His-GFP vs. 24 h: T7-6×His-GFP -0.7778 -1.700 to 
0.1444 
ns 0.1862 
8 h: T7-6×His-GFP vs. 24 h: GFP-6×His -0.1778 -1.100 to 
0.7444 
ns >0.9999 
8 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
-0.06667 -0.9888 to 
0.8555 
ns >0.9999 
8 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -1.944 -2.867 to -1.022 **** <0.0001 
8 h: GFP-6×His vs. 8 h: T7-GFP-G4S-MPG 0.1222 -0.7999 to 
1.044 
ns >0.9999 
8 h: GFP-6×His vs. 8 h: MPG-G4S-GFP -0.2444 -1.167 to 
0.6777 
ns 0.9991 
8 h: GFP-6×His vs. 24 h: T7-6×His-GFP -0.7667 -1.689 to 
0.1555 
ns 0.2031 
8 h: GFP-6×His vs. 24 h: GFP-6×His -0.1667 -1.089 to 
0.7555 
ns >0.9999 
8 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG -0.05556 -0.9777 to 
0.8666 
ns >0.9999 
8 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -1.933 -2.855 to -1.011 **** <0.0001 
8 h: T7-GFP-G4S-MPG vs. 8 h: MPG-G4S-
GFP 







8 h: T7-GFP-G4S-MPG vs. 24 h: T7-6×His-
GFP 
-0.8889 -1.811 to 
0.03326 
ns 0.0696 
8 h: T7-GFP-G4S-MPG vs. 24 h: GFP-6×His -0.2889 -1.211 to 
0.6333 
ns 0.996 
8 h: T7-GFP-G4S-MPG vs. 24 h: T7-GFP-G4S-
MPG 
-0.1778 -1.100 to 
0.7444 
ns >0.9999 
8 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 
-2.056 -2.978 to -1.133 **** <0.0001 
8 h: MPG-G4S-GFP vs. 24 h: T7-6×His-GFP -0.5222 -1.444 to 
0.3999 
ns 0.7579 
8 h: MPG-G4S-GFP vs. 24 h: GFP-6×His 0.07778 -0.8444 to 
0.9999 
ns >0.9999 
8 h: MPG-G4S-GFP vs. 24 h: T7-GFP-G4S-
MPG 
0.1889 -0.7333 to 
1.111 
ns >0.9999 
8 h: MPG-G4S-GFP vs. 24 h: MPG-G4S-GFP -1.689 -2.611 to -
0.7667 
**** <0.0001 
24 h: T7-6×His-GFP vs. 24 h: GFP-6×His 0.6 -0.3221 to 
1.522 
ns 0.568 
24 h: T7-6×His-GFP vs. 24 h: T7-GFP-G4S-
MPG 
0.7111 -0.2110 to 
1.633 
ns 0.3038 
24 h: T7-6×His-GFP vs. 24 h: MPG-G4S-GFP -1.167 -2.089 to -
0.2445 
** 0.0029 
24 h: GFP-6×His vs. 24 h: T7-GFP-G4S-MPG 0.1111 -0.8110 to 
1.033 
ns >0.9999 
24 h: GFP-6×His vs. 24 h: MPG-G4S-GFP -1.767 -2.689 to -
0.8445 
**** <0.0001 
24 h: T7-GFP-G4S-MPG vs. 24 h: MPG-G4S-
GFP 





















Table B. 4. Evaluating the effect of the protein concentration in the translocation into fungal cells. 
(Figure 3.10) 
Tukey's multiple comparisons test Mean 
difference 




1 h: T7-GFP-6×His 400 μM vs. 1 h: GFP-6×His 100 
μM 
0.15 -0.9329 to 
1.233 
ns 0.9998 
1 h: T7-GFP-6×His 400 μM vs. 1 h: MPG-G4S-GFP 
400 μM 
0.05 -1.033 to 
1.133 
ns >0.9999 
1 h: T7-GFP-6×His 400 μM vs. 1 h: MPG-G4S-GFP 
100 μM 
0.1167 -0.9663 to 
1.200 
ns >0.9999 
1 h: T7-GFP-6×His 400 μM vs. 24 h: T7-GFP-6×His 
400 μM 
-0.3 -1.383 to 
0.7829 
ns 0.9858 
1 h: T7-GFP-6×His 400 μM vs. 24 h: GFP-6×His 100 
μM 
-0.06667 -1.150 to 
1.016 
ns >0.9999 
1 h: T7-GFP-6×His 400 μM vs. 24 h: MPG-G4S-
GFP 400 μM 
-1.233 -2.316 to -
0.1504 
* 0.016 
1 h: T7-GFP-6×His 400 μM vs. 24 h: MPG-G4S-
GFP 100 μM 
-1.183 -2.266 to -
0.1004 
* 0.0237 
1 h: GFP-6×His 100 μM vs. 1 h: MPG-G4S-GFP 400 
μM 
-0.1 -1.183 to 
0.9829 
ns >0.9999 
1 h: GFP-6×His 100 μM vs. 1 h: MPG-G4S-GFP 100 
μM 
-0.03333 -1.116 to 
1.050 
ns >0.9999 
1 h: GFP-6×His 100 μM vs. 24 h: T7-GFP-6×His 400 
μM 
-0.45 -1.533 to 
0.6329 
ns 0.8825 
1 h: GFP-6×His 100 μM vs. 24 h: GFP-6×His 100 
μM 
-0.2167 -1.300 to 
0.8663 
ns 0.998 
1 h: GFP-6×His 100 μM vs. 24 h: MPG-G4S-GFP 
400 μM 
-1.383 -2.466 to -
0.3004 
** 0.0047 
1 h: GFP-6×His 100 μM vs. 24 h: MPG-G4S-GFP 
100 μM 
-1.333 -2.416 to -
0.2504 
** 0.0071 
1 h: MPG-G4S-GFP 400 μM vs. 1 h: MPG-G4S-GFP 
100 μM 
0.06667 -1.016 to 
1.150 
ns >0.9999 
1 h: MPG-G4S-GFP 400 μM vs. 24 h: T7-GFP-
6×His 400 μM 
-0.35 -1.433 to 
0.7329 
ns 0.9663 
1 h: MPG-G4S-GFP 400 μM vs. 24 h: GFP-6×His 
100 μM 
-0.1167 -1.200 to 
0.9663 
ns >0.9999 
1 h: MPG-G4S-GFP 400 μM vs. 24 h: MPG-G4S-
GFP 400 μM 
-1.283 -2.366 to -
0.2004 
* 0.0107 
1 h: MPG-G4S-GFP 400 μM vs. 24 h: MPG-G4S-
GFP 100 μM 
-1.233 -2.316 to -
0.1504 
* 0.016 
1 h: MPG-G4S-GFP 100 μM vs. 24 h: T7-GFP-
6×His 400 μM 
-0.4167 -1.500 to 
0.6663 
ns 0.918 
1 h: MPG-G4S-GFP 100 μM vs. 24 h: GFP-6×His 
100 μM 
-0.1833 -1.266 to 
0.8996 
ns 0.9993 
1 h: MPG-G4S-GFP 100 μM vs. 24 h: MPG-G4S-
GFP 400 μM 
-1.35 -2.433 to -
0.2671 
** 0.0062 
1 h: MPG-G4S-GFP 100 μM vs. 24 h: MPG-G4S-
GFP 100 μM 
-1.3 -2.383 to -
0.2171 
** 0.0093 
24 h: T7-GFP-6×His 400 μM vs. 24 h: GFP-6×His 
100 μM 
0.2333 -0.8496 to 
1.316 
ns 0.9969 
24 h: T7-GFP-6×His 400 μM vs. 24 h: MPG-G4S-
GFP 400 μM 







24 h: T7-GFP-6×His 400 μM vs. 24 h: MPG-G4S-
GFP 100 μM 
-0.8833 -1.966 to 
0.1996 
ns 0.1833 
24 h: GFP-6×His 100 μM vs. 24 h: MPG-G4S-GFP 
400 μM 
-1.167 -2.250 to -
0.08373 
* 0.0269 
24 h: GFP-6×His 100 μM vs. 24 h: MPG-G4S-GFP 
100 μM 
-1.117 -2.200 to -
0.03373 
* 0.0391 
24 h: MPG-G4S-GFP 400 μM vs. 24 h: MPG-G4S-
GFP 100 μM 
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